Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Por Kosmider, Olivier, Passet, Marie, Santini, Valeria, Platzbecker, Uwe, Andrieu, Valérie, Zini, Gina, Beyne-Rauzy, Odile, Guerci, Agnès, Masala, Erico, Balleari, Enrico, Bulycheva, Ekaterina, Dreyfus, François, Fenaux, Pierre, Fontenay, Michaela, Park, Sophie
Publicado no Haematologica (2016)

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Por Kelaidi, Charikleia, Stamatoullas, Aspasia, Beyne-Rauzy, Odile, Raffoux, Emmanuel, Quesnel, Bruno, Guerci, Agnes, Dreyfus, François, Brechignac, Sabine, Berthou, Christian, Prebet, Thomas, Hicheri, Yosr, Hacini, Maya, Delaunay, Jacques, Gourin, Marie-Pierre, Camo, Jean-Marie, Zerazhi, Hacene, Taksin, Anne-Laure, Legros, Laurence, Choufi, Bachra, Fenaux, Pierre
Publicado em 2010